LOGO Design

Class [005]
Medicines for human purposes for the treatment of lung cancer, breast cancer, hairy cell leukemia, chronic lymphocytic leukemia, Acute myelocytic leukemia, bladder cancer, lymphoma, ureteral cancer, ovarian cancer, endometrial carcinoma, carcinoma of uterine cervix, head and neck cancer, gastric cancer, liver cancer, esophageal cancer, pancreatic cancer, colorectal cancer, multiple myeloma, soft tissue sarcoma, melanoma tumor, Hodgkin's disease, testicular cancer, chorionic carcinoma, neuroblastoma, nephroblastoma, ewing sarcoma, rhabdomyosarcoma, Kaposi's sarcoma , and for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant; medicines for human purposes for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b), improving diabetes postprandial hyperglycemia, long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis, treatment of chronic congestive heart failure, multiple peripheral diabetic neuropathy; medicines for human purposes for the treatment of lower respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and skin structure infections, bacterial septicemia, gynecological infections, febrile neutropenic infections in combination with an aminoglycoside, bone and joint infections and polymicrobic infections; medicines for human purposes for the treatment of urethritis, non-gonococcal urethritis (NGU), prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, superficial pyogenic infection, deep suppurative disease, acute and chronic bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, suppurative lung disease, syphilis, otitis media, nasosinusitis, hypognathadenitis, dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, peritonitis and septicemia, bacteremia; medicines for human purposes for the treatment of complicated intra-abdominal infections, complicated skin and skin structure infections and community-acquired pneumonia; medicines for human purposes for the treatment of intra-abdominal infection, lower respiratory tract infections, gynecological infections, septicaemia, urogenital tract infection, bone and joint infection, skin and skin structure infections, endocarditis and for many bacteria resistant to cephalosporin class, namely aerobic and anaerobic gram-positive and gram-negative bacterial infection caused by potent antimicrobial activity; medicines for human purposes for the treatment of pneumonia, hospital acquired pneumonia, urinary tract infection, gynecological infections, endometritis, pelvic inflammation, skin and skin structure infections, meningitis, septicaemia for patients with adult granulocytopenia syndrome associated with fever and Patients with multiple infection; medicines for human purposes for the treatment of burn, surgery wound infection, pneumonia, chronic bronchitis, nephropyelitis, urocystitis, peritonitis, septicemia; medicines for human purposes for the treatment of neoplastic diseases; capsules for pharmaceutical purposes for hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b); pharmaceutical preparations for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b), improving diabetes postprandial hyperglycemia, long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis, treatment of chronic congestive heart failure, multiple peripheral diabetic neuropathy; chemico-pharmaceutical preparations for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b), improving diabetes postprandial hyperglycemia, long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis or a combination thereof, treatment of chronic congestive heart failure, multiple peripheral diabetic neuropathy; drugs for medical purposes for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b), improving diabetes postprandial hyperglycemia, long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics, digitalis and for treatment of chronic congestive heart failure; medicines for human purposes for the treatment of lower respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and skin structure infections, bacterial septicemia, gynecological infections, febrile neutropenic infections, bone and joint infections and polymicrobic infections; medicines for human purposes for the treatment of urethritis, non-gonococcal urethritis (ngu), prostatitis, gonorrhea, cystitis, epididymitis, intrauterine infection, pyelonephritis, endonephritis, pyelocystitis, superficial pyogenic infection, deep suppurative disease, acute and chronic bronchitis, asthmatoid bronchitis, bronchiectasis, alveobronchiolitis, bacterial pneumonia, allotype pneumonia, suppurative lung disease, syphilis, otitis media, nasosinusitis, hypognathadenitis, dysentery, enteritis, transmissible alimentary toxicosis, angiocholitis, cholecystitis, peritonitis and septicemia, bacteremia; medicines for human purposes for the treatment of complicated intra-abdominal infections, complicated skin and skin structure infections and community-acquired pneumonia; medicines for human purposes for the treatment of intra-abdominal infection, lower respiratory tract infections, gynecological infections, septicaemia, urogenital tract infection, bone and joint infection, skin and skin structure infections, endocarditis and for many bacteria resistant to cephalosporin class, including aerobic and anaerobic gram-positive and gram-negative bacterial infection caused by potent antimicrobial activity; medicines for human purposes for the treatment of pneumonia, hospital acquired pneumonia, urinary tract infection, gynecological infections, endometritis, pelvic inflammation, skin and skin structure infections, meningitis, and septicemia; medicines for human purposes for the treatment of burn, surgery wound infection, pneumonia, chronic bronchitis, nephropyelitis, urocystitis, peritonitis, septicaemia; capsules for the treatment of hyperlipidemia caused by Primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b); pharmaceutical preparations for medical purposes for pneumonia, hospital acquired pneumonia, urinary tract infection, gynecological infections, endometritis, pelvic inflammation, skin and skin structure infections, meningitis, and septicaemia; tablets for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia Fredrickson a and b), improving diabetes postprandial hyperglycemia long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis, treatment of chronic congestive heart failure, multiple peripheral diabetic neuropathy; chemical preparations for medical purposes for treatment of primary of hypertension, hyperglycemia and its associated symptoms, hyperlipidemia caused by primary hypercholesterolemia and primary mixed hyperlipidemia fredrickson a and b), improving diabetes postprandial hyperglycemia long-term treatment of coronary heart disease, prevention of angina pectoris, continued after myocardial infarction angina pectoris, diuretics and digitalis, treatment of chronic congestive heart failure, multiple peripheral diabetic neuropathy;